A world leader in the development and integration of innovative materials and components, Saint-Gobain creates customized single-use solutions for the biopharmaceutical market. Through our unparalleled technological expertise and worldwide resources, we develop integrated solutions for critical fluid management that meet your evolving needs.
Interdisciplinary Consortium Receives Grant to Develop Next-Generation Cell-Based Cancer Vaccines
Saint-Gobain Life Sciences and Kanyr Pharma partner with clinical experts at the Research Institute of McGill University Health Centre and engineers at McGill to develop new cell culture technologies.
May 22nd, 2020
November 22nd, 2019